Three key opinion leaders will make much-needed advancements in treatment options for Inflammatory Bowel Disease on new advisory panel.
We are innovating to help humanity achieve some of its most inspiring medical advancements in the 21st century. Read about Microba’s progress, partnership news and latest discoveries.
Precise measurement of the gut microbiome empowers new discoveries in research and the development of innovative treatments and diagnostics.
Using the NEW1000 Family Study, researchers will investigate the role of the microbiome in the developmental origins of health and disease.
Dr David Wood will present at the Microbiome Data Congress to discuss the importance of precise gut microbiome profiling for biomarker discovery.
A/Prof Lutz Krause and Dr David Wood discuss practical applications of metagenomics in microbiome discovery at ASM's Annual Scientific Meeting.
Microba Life Sciences has united with Illumina, Inc. to advance understanding of the human gut microbiome in human health and disease.
Published study found a method designed for preserving forensic DNA outperformed other commonly used faecal preservation methods.
Professor Hugenholtz will discuss approaches to using new tools and data in research and explain the different approaches to taxonomic classification.
Microba Community Profiler (MCP) outperforms existing profilers for accurate and comprehensive characterisation of the human gut microbiome.